 | Up a level |
Bayas, Antonios and Mansmann, Ulrich and Ön, Begum I. and Hoffmann, Verena S. and Berthele, Achim and Mühlau, Mark and Kowarik, Markus C. and Krumbholz, Markus and Senel, Makbule and Steuerwald, Verena and Naumann, Markus and Hartberger, Julia and Kerschensteiner, Martin and Oswald, Eva and Ruschil, Christoph and Ziemann, Ulf and Tumani, Hayrettin and Vardakas, Ioannis and Albashiti, Fady and Kramer, Frank and Soto-Rey, Inaki and Spengler, Helmut and Mayer, Gerhard and Kestler, Hans A. and Kohlbacher, Oliver and Hagedorn, Marlien and Boeker, Martin and Kuhn, Klaus and Buchka, Stefan and Kohlmayer, Florian and Kirschke, Jan S. and Behrens, Lars and Zimmermann, Hanna and Bender, Benjamin and Sollmann, Nico and Havla, Joachim and Hemmer, Bernhard and ProVal-MS study group (2024) Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study. Neurological Research and Practice, 6, Art.: 15, Paper / Clinical Trial Protocol. ISSN 2524-3489